Is Diffuse Large B-Cell Lymphoma Hereditary? Facts
At a Glance
Diffuse large B-cell lymphoma (DLBCL) is usually not hereditary: most genetic changes develop in lymphoma cells during a person’s life and are not passed to children. Rare inherited immune disorders or cancer syndromes may justify genetic counseling.
Usually no—diffuse large B-cell lymphoma (DLBCL) itself is generally not hereditary, and most patients do not pass it directly to their children. While you may hear your doctor describe your cancer as being driven by “genetic mutations,” this does not automatically mean you inherited the disease or that you will pass it down.
What This Means for Your Children
- It is generally not inherited: DLBCL arises from genetic changes acquired during a person’s life, not from something you caused or inherited [1].
- No routine screening is needed: Because the absolute risk to children is very low, there is generally no routine lymphoma screening (such as regular PET scans or specific blood tests) recommended for asymptomatic children of someone with DLBCL [2]. Children should simply receive standard preventive medical care and be evaluated if they develop persistent symptoms.
- Rare exceptions exist: A small number of cases are linked to rare, inherited immune-system disorders or broader cancer syndromes [3][4]. You should share your full family health history with your oncologist so they can determine if further evaluation is appropriate for your family.
Acquired vs. Inherited Mutations
When oncologists test your lymphoma, they are looking for “driver mutations” inside the cancer cells. These are genetic abnormalities that help the cancer grow and help doctors understand how best to treat it [5]. However, these are almost always acquired (or somatic) mutations [1][6].
- Acquired (somatic) mutations happen in certain cells after conception, during your lifetime [1]. They are generally not part of the egg or sperm lineage, meaning they cannot be passed down to your children.
- Inherited (germline) mutations are present from conception, exist in every cell in the body, and can be passed to the next generation. DLBCL is not typically associated with these inherited mutations [1][6].
It is important to note that the molecular testing done on your tumor biopsy is designed to look at the lymphoma cells, not your healthy tissue. While this tumor-only testing usually reflects acquired changes, it cannot completely rule out an inherited mutation. Confirming an inherited variant would require testing a non-tumor sample (like blood or saliva) [1].
Understanding the Familial Risk
While DLBCL is not passed directly from parent to child, population data shows that having a family history of non-Hodgkin lymphoma (the broad category that includes DLBCL) can modestly increase a relative’s overall risk.
Large studies in Nordic populations looked at the families of people with non-Hodgkin lymphoma [2]. They found:
- Relative Risk: First-degree relatives (parents, siblings, and children) have roughly a 1.4- to 1.6-fold higher relative risk of developing a lymphoma compared to the general public [2].
- Absolute Risk: While a “higher risk” sounds alarming, the absolute chance of developing the disease remains very small. The study found that the cumulative risk (from birth to age 79) for a child of someone with non-Hodgkin lymphoma is only about 1.4% [2].
These estimates are population averages and do not predict an individual child’s exact future, but they demonstrate that the vast majority of children born to a parent with DLBCL will never develop lymphoma.
When to Consider Genetic Counseling
In rare cases, lymphoma can be linked to inherited immune system deficiencies or broader family cancer syndromes [3][4]. You may want to ask your doctor about a referral to a genetic counselor if:
- You have multiple close family members who have had lymphoma, leukemia, or other blood cancers.
- Family members were diagnosed with cancers at unusually young ages.
- There is a known history of inherited immune disorders or unusual, repeated infections in your family.
Genetic counseling is an optional, risk-based service. A genetics professional will review your three-generation family history, help you consider whether germline (inherited) testing is medically appropriate for you, and discuss what the results might mean for your relatives’ health.
Common questions in this guide
Can diffuse large B-cell lymphoma be inherited from a parent?
Do children of someone with DLBCL need regular lymphoma screening?
Does a mutation found in my DLBCL mean my children inherited it?
How much does a family history of lymphoma increase a child's risk?
When should someone with DLBCL consider genetic counseling?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my molecular test performed only on the lymphoma, or was germline testing done from a non-cancer sample?
- 2.Does my personal or family history of other cancers or immune issues suggest I should speak with a genetic counselor?
- 3.If my children ever develop persistent symptoms like painless swollen lymph nodes, what history should they share with their own primary care doctor?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (6)
- 1
The Immunology of DLBCL.
Takahara T, Nakamura S, Tsuzuki T, Satou A
Cancers 2023; (15(3)) doi:10.3390/cancers15030835.
PMID: 36765793 - 2
Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
Fallah M, Kharazmi E, Pukkala E, et al.
Leukemia 2016; (30(2)):373-8 doi:10.1038/leu.2015.272.
PMID: 26442613 - 3
Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations.
Bronson AS, Zhu Y, Lilley CM, et al.
International journal of surgical pathology 2025; (33(3)):502-515 doi:10.1177/10668969241266933.
PMID: 39166368 - 4
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management.
Malpica L, Marques-Piubelli ML, Beltran BE, et al.
American journal of hematology 2022; (97(7)):951-965 doi:10.1002/ajh.26579.
PMID: 35472248 - 5
An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.
Schieppati F, Balzarini P, Fisogni S, et al.
Haematologica 2020; (105(5)):1369-1378 doi:10.3324/haematol.2019.223891.
PMID: 31399522 - 6
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment.
Liu Y, Barta SK
American journal of hematology 2019; (94(5)):604-616 doi:10.1002/ajh.25460.
PMID: 30859597
This page is for informational purposes only and is not medical advice. Your oncologist or a genetic counselor can assess your family history and testing needs.
Get notified when new evidence is published on Diffuse large B-cell lymphoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.